CD8A and ovarian cancer: In addition, LAG-3 and PD-1 are co-expressed on tumor infiltrating lymphocytes (TIL)-specific CD8+ T cells in the peripheral blood and tumors of ovarian cancer patients resulting in T cell dysfunction (142).